Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Chemmedchem
|
April 11, 2008
alpha,alpha-Cyclopentaneglycine dipeptides capped with biaryls as tachykinin NK(2) receptor antagonists
Marina Porcelloni, Piero D'Andrea, Cristina Rossi, et al.
F1000Research
|
November 8, 2024
A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison
Roberta Antonelli, Vittoria Forconi, Eleonora Molesti, et al.
European Journal of Pharmacology
|
March 27, 2004
Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists
Stefania Meini, Francesca Bellucci, Claudio Catalani, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 16, 2011
hNK2 receptor antagonists. The use of intramolecular hydrogen bonding to increase solubility and membrane permeability
Alessandro Ettorre, Piero D'Andrea, Sandro Mauro, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2002
Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: new antagonists for the human tachykinin NK-2 receptor
Nicholas J S Harmat, Danilo Giannotti, Rossano Nannicini, et al.
European Journal of Pharmacology
|
September 19, 2006
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist
Cecilia Cialdai, Manuela Tramontana, Riccardo Patacchini, et al.
European Journal of Pharmacology
|
June 1, 2005
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor
Stefania Meini, Claudio Catalani, Francesca Bellucci, et al.
Journal of Medicinal Chemistry
|
April 23, 2010
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor
Daniela Fattori, Marina Porcelloni, Piero D'Andrea, et al.
Children (Basel, Switzerland)
|
September 28, 2023
Natural Course of <i>IQSEC2</i>-Related Encephalopathy: An Italian National Structured Survey
Silvia Leoncini, Lidia Boasiako, Diego Lopergolo, et al.
Human Vaccines & Immunotherapeutics
|
January 28, 2026
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome
Ludovica Soldateschi, Silvia Leoncini, Fabio Fiorino, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Chemmedchem
|
April 11, 2008
alpha,alpha-Cyclopentaneglycine dipeptides capped with biaryls as tachykinin NK(2) receptor antagonists
Marina Porcelloni, Piero D'Andrea, Cristina Rossi, et al.
F1000Research
|
November 8, 2024
A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison
Roberta Antonelli, Vittoria Forconi, Eleonora Molesti, et al.
European Journal of Pharmacology
|
March 27, 2004
Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists
Stefania Meini, Francesca Bellucci, Claudio Catalani, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 16, 2011
hNK2 receptor antagonists. The use of intramolecular hydrogen bonding to increase solubility and membrane permeability
Alessandro Ettorre, Piero D'Andrea, Sandro Mauro, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2002
Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: new antagonists for the human tachykinin NK-2 receptor
Nicholas J S Harmat, Danilo Giannotti, Rossano Nannicini, et al.
European Journal of Pharmacology
|
September 19, 2006
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist
Cecilia Cialdai, Manuela Tramontana, Riccardo Patacchini, et al.
European Journal of Pharmacology
|
June 1, 2005
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor
Stefania Meini, Claudio Catalani, Francesca Bellucci, et al.
Journal of Medicinal Chemistry
|
April 23, 2010
Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor
Daniela Fattori, Marina Porcelloni, Piero D'Andrea, et al.
Children (Basel, Switzerland)
|
September 28, 2023
Natural Course of <i>IQSEC2</i>-Related Encephalopathy: An Italian National Structured Survey
Silvia Leoncini, Lidia Boasiako, Diego Lopergolo, et al.
Human Vaccines & Immunotherapeutics
|
January 28, 2026
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome
Ludovica Soldateschi, Silvia Leoncini, Fabio Fiorino, et al.
Page
of 5